Course Overview

  • Description

    The effectiveness of allergen specific immunotherapy has been demonstrated from several clinical trials throughout the world over the last 50 years. This lecture will focus on the studies that have demonstrated lasting effects following a course of immunotherapy. These studies include clinical benefits that extend beyond ending allergen and venom immunotherapy as well as prevention of asthma studies. Successful immunotherapy should have healthcare benefits resulting in less medication and office visits. Studies will be reviewed that have explored possible cost savings.

  • Objective

    To gain knowledge of studies that show immune modifying effects of immunotherapy and how immunotherapy can provide long term benefits for allergic individuals and cost saving to healthcare.


  • Greg  Plunkett, Ph.D

    Greg Plunkett, Ph.D

    Greg Plunkett currently works in the medical community providing consulting for allergy immunotherapy. He has over 37 years of experience with allergen manufacturing, quality control and regulations with 17 publications and over 65 abstracts. He most recently was the Director of the Allergy Research Lab for ALK USA allergen extract manufacturing since June 2001. The lab focused on the characterization of allergen source material and finished products including pollen, dander, fungal, insect and venom allergens. Prior to joining ALK, Dr. Plunkett served as a Research Scientist in the laboratories of Hollister-Stier where in addition to allergen characterization, he studied hymenoptera venom products and developed in vitro tests for diagnosing allergy. Dr. Plunkett sits on allergy immunotherapy committees for national allergy societies, is the Science officer for the US Allergen Manufacturers Association, and is a member of the FDA Allergenics Products Advisory Committee. Dr. Plunkett received a Bachelor’s degree in Chemistry from Cal State University, Fullerton and a Ph.D. from Washington State University in the field of biochemistry.


Enroll Now

In this 60 minute webinar learn how studies have demonstrated lasting effects following a course of immunotherapy.

Join AAAPC Today!

The Academy of Allergy and Asthma in Primary Care (AAAPC) is a national non-profit organization, which supports innovative care models for allergy and asthma care in the primary care setting. AAAPC assists physicians in expanding their role to provide high quality allergy care and therapy to the underserved patient population.